Table 1

Characteristics of the 78 patients with acute myeloid leukemia (AML) receiving dynamic contrast-enhanced magnetic resonance image (DCE-MRI)

VariableNo. of patients (%)
Male 37 (47) 
Female 41 (53) 
Age, y* 49 (17-76) 
FAB classification*  
    M0 1 (1.3) 
    M1 16 (20.5) 
    M2 31 (39.8) 
    M3 5 (6.4) 
    M4 16 (20.5) 
    M5 4 (5.1) 
    M6 4 (5.1) 
    Unclassified 1 (1.3) 
Karyotype  
    Favorable 14 (18.0) 
    Intermediate 52 (66.7) 
    Unfavorable 10 (12.8) 
    Unknown 2 (2.5) 
Follow-up, mo* 16.2 (4-34.3) 
CR 57 (73.1) 
CR duration, mo* 9.0 (1-33.4) 
Overall survival, mo* 11.3 (0.4-34.3) 
VariableNo. of patients (%)
Male 37 (47) 
Female 41 (53) 
Age, y* 49 (17-76) 
FAB classification*  
    M0 1 (1.3) 
    M1 16 (20.5) 
    M2 31 (39.8) 
    M3 5 (6.4) 
    M4 16 (20.5) 
    M5 4 (5.1) 
    M6 4 (5.1) 
    Unclassified 1 (1.3) 
Karyotype  
    Favorable 14 (18.0) 
    Intermediate 52 (66.7) 
    Unfavorable 10 (12.8) 
    Unknown 2 (2.5) 
Follow-up, mo* 16.2 (4-34.3) 
CR 57 (73.1) 
CR duration, mo* 9.0 (1-33.4) 
Overall survival, mo* 11.3 (0.4-34.3) 

FAB indicates French-American-British classification; and CR, complete remission.

*

Data are shown as median (range).

Favorable, t(8;21), inv(16), t(15;17); unfavorable, −7, del(7q), −5, del(5q), 3q abnormality; complex; intermediate, normal karyotype, and other abnormalities.

Close Modal

or Create an Account

Close Modal
Close Modal